The treatment of psoriasis and psoriatic arthritis: An interdisciplinary approach

被引：26

作者：

Gordon, KB

Ruderman, EM

机构：

[1] Evanston NW Healthcare, Div Dermatol, Skokie, IL 60077 USA

[2] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期

关键词：

D O I：

10.1016/j.jaad.2005.10.052

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Psoriatic arthritis is a common inflammatory arthritis associated with psoriasis, occurring in 5% to 40% of patients with Cutaneous disease. Recently, there has been an increased appreciation of the need to use an integrated approach to these 2 diseases, considering both entities when determining therapeutic choices. In this review, the available therapeutic options for psoriatic arthritis are considered, along with the potential benefit that these medications may have for cutaneous psoriasis. Finally, a conceptual model for the therapy of psoriasis and psoriatic arthritis, the Four Quadrant Model, is presented as a simplified framework to use when considering treatment for psoriatic disease.

引用

页码：S85 / S91

页数：7

共 31 条

[1] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial [J].

Antoni, C ;

Krueger, GG ;

de Vlam, K ;

Birbara, C ;

Beutler, A ;

Guzzo, C ;

Zhou, B ;

Dooley, LT ;

Kavanaugh, A .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1150-1157

[2]

Antoni C, 2002, ARTHRITIS RHEUM-US, V46, pS381

[3] Diagnosis and management of psoriatic arthritis [J].

Brockbank, J ;

Gladman, D .

DRUGS, 2002, 62 (17) :2447-2457

[4] AAD consensus statement on psoriasis therapies [J].

Callen, JP ;

Krueger, GG ;

Lebwohl, M ;

McBurney, EI ;

Mease, P ;

Menter, A ;

Paller, AS ;

Pariser, DM ;

Weinblatt, M ;

Zimmerman, G .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (05) :897-899

[5]

Clegg DO, 1999, ARTHRITIS RHEUM, V42, P2325, DOI 10.1002/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO

[6]

2-C

[7] Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].

Clegg, DO ;

Reda, DJ ;

Mejias, E ;

Cannon, GW ;

Weisman, MH ;

Taylor, T ;

BudimanMak, E ;

Blackburn, WD ;

Vasey, FB ;

Mahowald, ML ;

Cush, JJ ;

Schumacher, HR ;

Silverman, SL ;

Alepa, FP ;

Luggen, ME ;

Cohen, MR ;

Makkena, R ;

Haakenson, CM ;

Ward, RH ;

Manaster, BJ ;

Anderson, RJ ;

Ward, JR ;

Henderson, WG .

ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020

[8] SULFASALAZINE IN THE TREATMENT OF SPONDYLARTHROPATHY - A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

DOUGADOS, M ;

VANDERLINDEN, S ;

LEIRISALOREPO, M ;

HUITFELDT, B ;

JUHLIN, R ;

VEYS, E ;

ZEIDLER, H ;

KVIEN, TK ;

OLIVIERI, I ;

DIJKMANS, B ;

BERTOUCH, J ;

BROOKS, P ;

EDMONDS, J ;

MAJOR, G ;

AMOR, B ;

CALIN, A .

ARTHRITIS AND RHEUMATISM, 1995, 38 (05) :618-627

[9] Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate [J].

Genovese, MC ;

Cohen, S ;

Moreland, L ;

Lium, D ;

Robbins, S ;

Newmark, R ;

Bekker, P .

ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1412-1419

[10]

GLADMAN D, 1988, OXFORD TXB RHEUMATOL, P1071

← 1 2 3 4 →